Tyme Technologies Inc. (TYME)

[mcsharkey]

Kem Cho Hanuman:). Been picking up blocks of shares here myself. Buyer beware though. Scientific American article glorifying us was ahh, contracted and probably self-edited:
Link to Great ArticleA Trickster Enters the Fight Against Metastatic Cancers

This article was produced for TYME by Scientific American Custom Media, a division separate from the magazine's board of editors. Citation extracted from the article just blows me away, as it hadn't been documented in anything I can find

SM-88 was specifically designed to target the cancer cell and spare the patient’s healthy cells. To date, that has been proven in clinical trials. SM-88 has demonstrated confirmed responses in patients across 15 different tumor types with only two out of approximately 180 patients having serious adverse events, possibly or probably, related to SM-88. For perspective, the most commonly used pancreatic cancer regimens have more than 50% of patients experiencing drug related serious adverse even

Ahh, that's a fairly large pool of trial patients been flying under the wire.

This just seems so good.

GLTUA